Vaz-PereiraSMarquesIPMatiasJMiraFRibeiroLFloresRReal-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.Eur J Ophthalmol. 2017 doi: 10.5301/ejo.5000943.
2.
EpsteinDLAlgverePVvon WendtGSeregardSKvantaABenefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.Ophthalmology. 2012;119(12):2587–2591.
3.
CampochiaroPABrownDMAwhCCet al.Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.Ophthalmology. 2011;118(10):2041–2049.
4.
CălugăruDCălugăruMIntravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study.J Ocul Pharmacol Ther. 2015;31(2):78–86.
